ASTRAZEN.BOASTRAZEN.BOBSE
Loading
EBITDA Margin Over TimeContracting
Percentile Rank50
3Y CAGR-2.7%
5Y CAGR-6.4%
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

3Y CAGR
-2.7%/yr
vs +9.8%/yr prior
5Y CAGR
-6.4%/yr
Recent acceleration
Acceleration
-12.5pp
Decelerating
Percentile
P50
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
202511.53%-36.6%
202418.19%+20.8%
202315.05%+20.1%
202212.53%-31.5%
202118.30%+13.8%
202016.07%+33.6%
201912.03%+39.4%
20188.63%+3.2%
20178.36%+174.0%
20163.05%-